AUXILIUM PHARMACEUTICALS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011	FY2010 12 months to Dec 31, 2010
Net revenues
Operating expenses*:
Cost of goods sold
Research and development
Selling, general and administrative
Amortization of purchased intangibles
Contingent consideration
Total operating expenses
Income (loss) from operations
Interest expense
Basic and diluted net loss per common share
Other income, net
Income (loss) before income taxes
Income tax benefit
Net income (loss)
Net income (loss) per common share:
Basic (in dollars per share)
Diluted (in dollars per share)
Shares used to compute net income (loss) per common share:
Basic (in shares)
Diluted (in shares)
Stock-based compensation expense
Cost of goods sold
Research and development
Selling, general and administrative
Total stock-based compensation expense
Investment income (loss), net
Basic and diluted net loss per common share (in dollars per share)

Comments